Speaker illustration

Professor Jane Armitage

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Jane Armitage is Professor of Clinical Trials and Epidemiology in the Nuffield Department of Population Health (NDPH) at the University of Oxford and Honorary Consultant in Public Health Medicine at the Oxford University Hospital. She joined the Clinical Trial Service Unit, now part of NDPH, in 1990 from a background in clinical medicine, with particular experience in respiratory medicine, geriatrics and diabetes. She has co-ordinated a series of large-scale randomised trials including the MRC/BHF Heart Protection Study, SEARCH and HPS2-THRIVE, which are trials of lipid modification in people with or at risk of vascular disease, as well as the ASCEND trial of aspirin and fish oils in diabetes. Her main research interests are in lipids and the epidemiology of cardiovascular and other chronic disease. She is Course Director for the Oxford University Master’s in Clinical Trials starting in 2020.

What's next to reduce cardiovascular risk?

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Symposium

Thumbnail

ESC Geoffrey Rose Lecture in Population Sciences and Florence Nightingale Lecture in Nurse-Led Research

Event: ESC Congress 2021 - The Digital Experience

Topic: European Society of Cardiology

Session type: Special Session

Thumbnail

Would you give it to your grandmother? - Primary prevention in the elderly

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention

Session type: Symposium

Thumbnail

Launch of new Oxford Master’s in Clinical Trials

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology

Session type: Professional Development

Thumbnail

Starting is easy, stopping may not be: how long should we give cardiovascular drugs?

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Young Investigator Award Session Population Sciences

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Young Investigator Award Abstracts

Thumbnail

New insights in statin therapy

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Advances in Science

Thumbnail

This platform is supported by

logo Novo Nordisk